http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-33979-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2011-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f766c13e234225bb10cec9bb4fe438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6c7a6f2271ddafbea20cda78f81a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d469af202645310fc71735829ffc0cd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46726b1c0e469e7b3edc3890e5e1e5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_592c722796f0508edbaca4780dab1e51
publicationDate 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-33979-B1
titleOfInvention PIPERAZINES AS ANTIMALARIAL AGENTS
abstract This invention relates to novel derivatives of piperazine of the first formulation and their use as active ingredients in the preparation of pharmaceutical formulations. This invention also provides related aspects, including pharmaceutical formulations containing one or many of these compounds and their use as drugs in the prophylaxis or treatment of protozoal infections, for example, in particular, malaria. Formula (i).
priorityDate 2010-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724

Total number of triples: 33.